Vincerx Pharma Inc

NASDAQ:VINC   3:59:54 PM EDT
1.41
+0.09 (+6.82%)
Earnings Announcements

Vincerx Pharma Provides Key Strategic Update

Published: 06/06/2022 21:39 GMT
Vincerx Pharma Inc (VINC) - Vincerx Pharma Provides Key Strategic Update.
Vincerx Pharma Inc - Prioritizing Phase 1b Vip152 Studies to Focus on Double-hit Dlbcl and Cll.
Vincerx Pharma - Ind Filings for Vip236 in 2h22 and for Vip943 in 2h23 Remain on Track.
Vincerx Pharma Inc - Streamlining and Realigning Resources to Support Key Indications and Programs; Extending Estimated Cash Runway Into Late 2024.
Vincerx Pharma - Implementing Certain Cost Reduction Measures, Including a 33% Reduction of Full-time Employees.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.85

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.61

More details on our Analysts Page.